Literature DB >> 6438248

Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed.

B Olson, R A Weinstein, C Nathan, W Chamberlin, S A Kabins.   

Abstract

The epidemiology of Pseudomonas aeruginosa was evaluated in an intensive care unit for a period of six months by means of serial surveillance and environmental cultures. One hundred (37%) of 270 patients were noted to be colonized: 63 at the time of their admission and 37 during their stay on the unit. Colonization at the time of admission was associated with length of hospitalization before admission to the intensive care unit, age, gastrointestinal disease, and prior use of antibiotics. The strains acquired on the intensive care unit represented several different serotypes, with little clustering; the source of most strains was not found. In only 12 cases did the acquisition of P. aeruginosa appear to represent cross-infection; the use of barrier isolation could have prevented at most five of these cases. Undetected endogenous gastrointestinal carriage may have been responsible for many other apparent acquisitions. Clinical infection in association with preceding gastrointestinal colonization developed in 20 patients. The data indicate that traditional control measures aimed at the prevention of exogenous acquisition of P. aeruginosa are unlikely to have an impact on the overall incidence of infection and that efforts to prevent infection in patients who are already colonized are necessary.

Entities:  

Mesh:

Year:  1984        PMID: 6438248     DOI: 10.1093/infdis/150.6.808

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

1.  Role of Antimicrobial Stewardship in Prevention and Control of Antibiotic Resistance.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

Review 3.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

4.  Antibiotic susceptibility of clinical isolates of Pseudomonas aeruginosa.

Authors:  C Cervantes-Vega; J Chavez; M G Rodriguez
Journal:  Antonie Van Leeuwenhoek       Date:  1986       Impact factor: 2.271

Review 5.  Selective decontamination of the digestive tract.

Authors:  P J Sanderson
Journal:  BMJ       Date:  1989-12-09

6.  Molecular epidemiological study of Pseudomonas aeruginosa isolates from patients with acute leukemia.

Authors:  W Kern; C Wolz; G Döring
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

7.  Pseudomonas aeruginosa clinical isolates: serotypes, resistance phenotypes and plasmid profiles.

Authors:  M Millesimo; G de Intinis; M G Chirillo; T Musso; D Savoia
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

Review 8.  Influence of architectural design on nosocomial infections in intensive care units--a prospective 2-year analysis.

Authors:  J Huebner; U Frank; I Kappstein; H M Just; G Noeldge; K Geiger; F D Daschner
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

9.  Patterns of colonization by Pseudomonas aeruginosa in intubated patients: a 3-year prospective study of 1,607 isolates using pulsed-field gel electrophoresis with implications for prevention of ventilator-associated pneumonia.

Authors:  Jordi Vallés; Dolors Mariscal; Pilar Cortés; Pere Coll; Ana Villagrá; Emili Díaz; Antonio Artigas; Jordi Rello
Journal:  Intensive Care Med       Date:  2004-07-09       Impact factor: 17.440

10.  Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis.

Authors:  C Dupeyron; N Mangeney; L Sedrati; B Campillo; P Fouet; G Leluan
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.